[RESULTS OF CLINICAL TESTS OF A NEW CYTOSTATIC SUBSTANCE FROM THE METHYLHYDRAZINE SERIES (NATULAN)].
D000970:Antineoplastic Agents; D004358:Drug Therapy; D006689:Hodgkin Disease; D006801:Humans; D006834:Hydrazines; D007938:Leukemia; D007945:Leukemia, Lymphoid; D008223:Lymphoma; D008228:Lymphoma, Non-Hodgkin; D008763:Methylhydrazines; D010954:Plasmacytoma; D011344:Procarbazine
D000970:Antineoplastic Agents; D006834:Hydrazines; D008763:Methylhydrazines; D011344:Procarbazine
ANTINEOPLASTIC AGENTS; DRUG THERAPY; HODGKIN'S DISEASE; HYDRAZINES; LEUKEMIA, LYMPHOCYTIC; LYMPHOSARCOMA; PLASMACYTOMA
ERGEBNISSE DER KLINISCHEN PRUEFUNG EINER NEUEN ZYTOSTATISCHEN SUBSTANZ AUS DER METHYLHYDRAZINREIHE (NATULAN)